AL-15469A for the Treatment of Bacterial Conjunctivitis

Completed · Phase 3

Conditions studied: Bacterial Conjunctivitis

In brief

The purpose of the study is to determine whether AL-15469A is safe and effective in the treatment of bacterial conjunctivitis.

Key facts

Study ID

NCT00332293

Run by

Alcon Research

People needed

695

Starts

2006-05-01

Expected to finish

2006-12-01

Last updated by the study team

2016-11-18

Who can join

Age: 0 and older. Sex: any. Healthy volunteers: not accepted.

You may qualify if…

• signs and symptoms of bacterial conjunctivitis
• Other protocol-defined inclusion criteria may apply

You may not qualify if…

• under 1 mo. age
• Other protocol-defined exclusion criteria may apply

Where it is running

• Contact Alcon for Trial Locations — Fort Worth, Texas, United States

Full record on ClinicalTrials.gov

Trial information comes from ClinicalTrials.gov and is refreshed daily. TrialsForMe does not provide medical care and does not run the studies it lists.